EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹7.98 Cr | ₹-11 Cr | ₹-5.10 Cr | ₹5.32 Cr | ₹12 Cr |
What is the latest Net Current Assets ratio of EVEREST ORGANICS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹7.98 Cr |
| Mar2024 | ₹-11 Cr |
| Mar2023 | ₹-5.10 Cr |
| Mar2022 | ₹5.32 Cr |
| Mar2021 | ₹12 Cr |
How is Net Current Assets of EVEREST ORGANICS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.98 Cr | Positive | |
| Mar2024 | ₹-11 Cr | Negative | |
| Mar2023 | ₹-5.10 Cr | Negative | |
| Mar2022 | ₹5.32 Cr | -55.29 | |
| Mar2021 | ₹12 Cr | - | |
Compare Net Current Assets of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹244.8 Cr | -5.7% | 5.3% | -42.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,893.0 Cr | -0.2% | 7.5% | 5.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,367.0 Cr | -0.9% | 11.5% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,241.0 Cr | 0.5% | 7% | 37.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,010.0 Cr | -3.1% | 4.8% | 10.3% | Stock Analytics | |
| CIPLA | ₹104,366.0 Cr | -5.4% | 5.5% | -13.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -5.7% |
5.3% |
-42.1% |
| SENSEX | -3.2% |
-3.9% |
-7.5% |
You may also like the below Video Courses